SGLT2 inhibitors lead the conversation for most people with type 2 diabetes and CKD, GLP-1 agonists add complementary benefit, metformin still fits at most eGFR levels with the right dose, and insulin remains the dependable option when the others run out of room
For protocols aiming for synergy with other peptides, our team generally sees more value in CJC-1295 without DAC (Mod GRF 1-29)
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
This can include: Frequent thoughts about specific foods, particularly those high in sugar or fat Difficulty feeling satisfied after meals, leading to continued eating Planning meals or snacks excessively throughout the day Emotional distress when food is unavailable or restricted The impact on eating behaviour can be substantial
What to bring to appointments To make the most of visits with your clinician, you can bring notes on things youve noticed and any questions you have